More than a week after Australia’s largest private health insurer, Medibank Private Ltd (ASX: MPL), began trading on the ASX, investors will finally be able dispose of their shares on a normal settlement trading basis.
This comes after myopic retail traders were left with feelings of “anger and frustration” – according to the Fairfax Press – when they realised their shares could not be traded immediately for a stag profit.
For long-term investors unappeased by the modest 7% increase in the value of their Medibank shares since they floated 10 days ago, the question of whether the share price will be sold down may be concerning.
However analysts, such as The Motley Fool’s Matt Joass, believe fair value is slightly above $2.00 per share – a modest extension on the final price retail investors paid for their shares.
Given the current market price for Medibank is around $2.15, their valuation does not appear to imply a gross overvaluation, and therefore I’d say it’s unlikely we’ll see a dramatic sell off any time soon.
We hear it over and over from investors, "I wish I had bought Altium or Afterpay when they were first recommended by The Motley Fool. I'd be sitting on a gold mine!" And it's true.
And while Altium and Afterpay have had a good run, we think these 5 other stocks are screaming buys. And you can buy them now for less than $5 a share!
*Extreme Opportunities returns as of June 5th 2020
Motley Fool Contributor Owen Raszkiewicz owns shares of Medibank Private Ltd. You can follow Owen on Twitter @ASXinvest.
- ALL ORDINARIES finishes higher Monday: 10 shares you missed – October 30, 2017 4:44pm
- Are these the secrets behind Australia’s best ASX investors? – October 30, 2017 3:43pm
- My Aussie Share Market Investing Do’s of 2017/2018 – October 30, 2017 1:13pm